Literature DB >> 25923125

Migraine aura: new ideas about cause, classification, and clinical significance.

Andrew Charles1, Jakob Møller Hansen.   

Abstract

PURPOSE OF REVIEW: The migraine aura is a dramatic spontaneous change in brain activity resulting in a variety of transient neurological symptoms. The purpose of this review is to address recent advances in the understanding of aura and its role in migraine. RECENT
FINDINGS: The formal classification of migraine aura is becoming both broader and more detailed. Traditionally viewed as a primary event that triggers a migraine attack, studies regarding the timing of aura relative to other symptoms of migraine indicate that it may not in fact play a primary role in initiating an attack. Careful recording and analysis of visual aura symptoms provides new insight into the initiation and propagation of the underlying brain phenomenon, and the different regions of visual cortex that produce different visual perceptions. Migraine with aura may have different responses to acute and preventive therapies.
SUMMARY: There has been significant evolution of concepts regarding the causes of migraine aura, how it is best defined, and how it fits into the picture of the migraine disorder as a whole. Regardless of its exact role in the genesis of migraine, an increased understanding of aura has the potential to provide important new insight into not only migraine but also fundamental mechanisms of brain physiology.

Entities:  

Mesh:

Year:  2015        PMID: 25923125     DOI: 10.1097/WCO.0000000000000193

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  18 in total

Review 1.  Spreading Depression in Primary and Secondary Headache Disorders.

Authors:  Shih-Pin Chen; Cenk Ayata
Journal:  Curr Pain Headache Rep       Date:  2016-07

Review 2.  How Well Does the ICHD 3 (Beta) Help in Real-Life Migraine Diagnosis and Management?

Authors:  Sait Ashina; Jes Olesen; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2016-12

3.  Predictors of Triptan Response in Pediatric Migraine.

Authors:  Hannah F Johnson; Peter J Goadsby; Amy A Gelfand
Journal:  Pediatr Neurol       Date:  2016-03-08       Impact factor: 3.372

4.  Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women.

Authors:  Tobias Kurth; Pamela M Rist; Paul M Ridker; Gregory Kotler; Vadim Bubes; Julie E Buring
Journal:  JAMA       Date:  2020-06-09       Impact factor: 56.272

5.  Migraine-Like Visual Auras Among Traumatized Cambodians with PTSD: Fear of Ghost Attack and Other Disasters.

Authors:  Devon E Hinton; Ria Reis; Joop de Jong
Journal:  Cult Med Psychiatry       Date:  2018-06

Review 6.  Optical Coherence Tomography in Patients with Chronic Migraine: Literature Review and Update.

Authors:  Francisco J Ascaso; Sara Marco; Javier Mateo; Mireya Martínez; Olivia Esteban; Andrzej Grzybowski
Journal:  Front Neurol       Date:  2017-12-13       Impact factor: 4.003

Review 7.  CGRP and the Trigeminal System in Migraine.

Authors:  Smriti Iyengar; Kirk W Johnson; Michael H Ossipov; Sheena K Aurora
Journal:  Headache       Date:  2019-04-14       Impact factor: 5.887

8.  Foveal Thickness Alterations in Patients with Migraine.

Authors:  Cem Cankaya; Mehmet Tecellioglu
Journal:  Med Arch       Date:  2016-04-01

9.  Headache symptoms from migraine patients with and without aura through structure-validated self-reports.

Authors:  Jiawei Wang; Bingren Zhang; Chanchan Shen; Jinhua Zhang; Wei Wang
Journal:  BMC Neurol       Date:  2017-10-12       Impact factor: 2.474

10.  Migraine with aura in women is not associated with structural thalamic abnormalities.

Authors:  Anders Hougaard; Silas Haahr Nielsen; David Gaist; Oula Puonti; Ellen Garde; Nina Linde Reislev; Pernille Iversen; Camilla Gøbel Madsen; Morten Blaabjerg; Helle Hvilsted Nielsen; Thomas Krøigård; Kamilla Østergaard; Kirsten Ohm Kyvik; Kristoffer Hougaard Madsen; Hartwig Roman Siebner; Messoud Ashina
Journal:  Neuroimage Clin       Date:  2020-07-25       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.